Skip to main content
. 2019 Feb 27;13:68. doi: 10.3389/fncel.2019.00068

FIGURE 1.

FIGURE 1

Changes of body weight, blood glucose and plasma insulin in T2DM rat. (A) Body weight; (B) blood glucose; (C) plasma insulin. Rats in the model group showed a significant increase of blood glucose, and a significant decrease of body weight and plasma insulin. The COX2 inhibitor have no effect on the body weight, blood glucose, and plasma insulin. Data are expressed as mean ± SD of nine individual rats in each group, and were analyzed statistically using one-way ANOVA, followed by post hoc Tukey’s test. ∗∗P < 0.01 compared with normal group.